亞洲抗衰老協會 第七屆會員周年大會 醫學講座 200 7 年12月 4 日

Download 亞洲抗衰老協會 第七屆會員周年大會 醫學講座 200 7 年12月 4 日

If you can't read please download the document

Upload: dagan

Post on 08-Jan-2016

59 views

Category:

Documents


16 download

DESCRIPTION

亞洲抗衰老協會 第七屆會員周年大會 醫學講座 200 7 年12月 4 日. 「癌症的化驗診斷 及 中西並治的概念」. 一 . 香港的癌症數字 二 . 癌症的化驗診斷 三 . 癌症的中西並治概念. 一 . 2004 年香港的癌症數字 1. 10 Most Common Cancers (Male). 一 . 2004 年香港的癌症數字 2. 10 Major Causes of Cancer Deaths (Male). 一 . 2004 年香港的癌症數字 3. 10 Most Common Cancers (Female). - PowerPoint PPT Presentation

TRANSCRIPT

  • 2007124

  • .

    .

    .

  • . 2004

    1. 10 Most Common Cancers (Male)

  • . 2004

    2. 10 Major Causes of Cancer Deaths (Male)

  • . 2004

    3. 10 Most Common Cancers (Female)

  • . 2004

    4. 10 Major Causes of Cancer Deaths (Female)

  • . ?

    X-ray, US, CT, MRI, PET etc.

  • (Tumour Markers)

    1. (1) ( Neuron specific enolase NSE) 60% ~ 80%90% 10% ~ 20%

    (Squanous cell carcinoma antigen, SCCA) ( )

    (Carcinoembryonic antigen, CEA) 20%

  • (2) CEA - CEA

    - 24%3.6%

    -

    CA 19.9 CA72.4AFP

  • 15.3 (Carbohydrate antigen 15.3CA15.3)

    - 0 I0%II 1%III12% 78%

    -

    CEA

  • (Alpha-fetoprotein, AFP)

    - 70% ~ 80%80% ~ 90% 35% AFP

    -

    -

    CA19.9CA72.4 CEA Gamma-GTALP

  • 72.4(Carbohydrate antigen 72.4, CA72.4)

    -

    - 28% ~ 59%CEA

    CEA

  • EB(EBV antibodies)

    - (EA IgAEA IgG)(VCA IgA) 80%EA IgAVCA IgA( 1/10)

    EB95%98% EB 99%

  • 19.9(Carbohydrate antigen 19.9, CA19.9)

    - (I < 5%III IV)

    CEA

  • (Squamous cell carcinoma antigen, SCCA)

    -

    (Pap smear)

  • 125(Carbohydrate antigen 125, CA125) - 25 u/ml 35 u/ml

    - 55 u/ml 70% - 80%CA125

    Beta-hCG

  • (Tumour Markers)- (Alkaline phosphatase, ALP)- (Lactate dehydrogenase, LDH)- (Gamma-glutamyl transferase, GGT)- (Ferritin)- C(C-reactive protein, CRP)- (Erythrocyte sedimentation rate, ESR) (Leukaemia): (Complete blood count / picture, CBC / CBP)

  • .

  • I.

    1. 2. 3. 4.

  • II.

    )

  • III. (1) 1/.

    2/.

    3/.

  • 1/.

    2/.

    3/. 4/.

  • III. (1)

    (2)

    (3)

  • 3. (1) ()

    (2) (3) 1) 2) 3)

  • IV. ?